Swiss National Bank »

Apogee Therapeutics shares owned by Swiss National Bank

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Swiss National Bank from 13F filings

Historical chart of Swiss National Bank investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Swiss National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Swiss National Bank

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.7M 41k 66.45
2023-12-31 $922k 33k 27.94